DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
Public ClinicalTrials.gov record NCT03643224. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Clinical Evaluation of the DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.
Study identification
- NCT ID
- NCT03643224
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 376 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 19, 2018 (Actual)
- Primary completion
- Oct 31, 2024 (Actual)
- Completion
- Oct 31, 2024 (Actual)
- Last update posted
- Oct 23, 2025
2018 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Grandview Medical Center | Birmingham | Alabama | 35242 | — |
| University Of Alabama | Birmingham | Alabama | 35294 | — |
| Keck School Of Medicine | Los Angeles | California | 90033 | — |
| Advent Health, Florida Hospital Orlando | Orlando | Florida | 32751 | — |
| Iowa Heart Center | West Des Moines | Iowa | 50266 | — |
| Kansas City Heart Rhythm Institute | Overland Park | Kansas | 66211 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Jackson Heart Clinic | Jackson | Mississippi | 39216 | — |
| North Mississippi Medical Center | Tupelo | Mississippi | 38801 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Montefiore Medical Center | New York | New York | 10467 | — |
| Trident Medical Center | Charleston | South Carolina | 29406 | — |
| Medical University Of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Cardiac Arrhythmia Research Foundation | Austin | Texas | 78705 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03643224, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 23, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03643224 live on ClinicalTrials.gov.